Technology

In this June 5, 2017 photo, former Secretary of State Hillary Clinton speaks at a fundraiser for the Elijah Cummings Youth Program in Israel in Baltimore. The FBI’s Hillary Clinton email investigation that ended without charges remains a lingering grievance for President Donald Trump, who holds it up as an example of a “rigged” system. (AP Photo/Patrick Semansky)
September 01, 2017 - 11:09 am
WASHINGTON (AP) — The FBI's Hillary Clinton email investigation that ended last year without charges remains a lingering grievance for President Donald Trump, who for months has held it up as an example of a "rigged" criminal justice system that shielded his Democratic opponent from punishment for...
Read More
August 31, 2017 - 4:11 pm
NEW YORK (AP) — The latest on developments in financial markets (All times local): 4 p.m. Stocks are closing solidly higher for the second day in a row after the government said spending by consumers strengthened. Health care and technology companies made some of the largest gains Wednesday...
Read More
Brooke Henderson, of Canada, salutes the crowd after finishing up on the 18th hole during the final round of the Canadian Pacific Women's Open golf tournament in Ottawa, Ontario, Sunday, Aug. 27, 2017. (Adrian Wyld/The Canadian Press via AP)
August 31, 2017 - 9:40 am
NORTON, Mass. (AP) — Adam Scott was a surprise arrival to the Dell Technologies Championship for the second event in the FedEx Cup playoffs. He was planning to skip the opening two playoff events, and thus end his season, because his wife was expecting their second child in Australia. Their son was...
Read More
In this July 9, 2015, photo, provided by Novartis Pharmaceuticals Corp., human T cells belonging to cancer patients arrive at Novartis Pharmaceuticals Corp.'s Morris Plains, N.J., facility. The Food and Drug Administration (FDA) approved the first treatment that genetically engineers patients’ own blood cells into an army of leukemia-fighting assassins. Manufacturer Novartis will create those turbocharged cells in this facility and ship them back to hospitals to infuse into patients. (Brent Stirton/Novartis Pharmaceuticals Corp. via AP)
August 31, 2017 - 6:50 am
WASHINGTON (AP) — Opening a new era in cancer care, U.S. health officials have approved a breakthrough treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia. The Food and Drug Administration said the approval on Wednesday was...
Read More
In this July 9, 2015, photo, provided by Novartis Pharmaceuticals Corp., human T cells belonging to cancer patients arrive at Novartis Pharmaceuticals Corp.'s Morris Plains, N.J., facility. The Food and Drug Administration (FDA) approved the first treatment that genetically engineers patients’ own blood cells into an army of leukemia-fighting assassins. Manufacturer Novartis will create those turbocharged cells in this facility and ship them back to hospitals to infuse into patients. (Brent Stirton/Novartis Pharmaceuticals Corp. via AP)
August 31, 2017 - 6:50 am
WASHINGTON (AP) — Opening a new era in cancer care, U.S. health officials have approved a breakthrough treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia. The Food and Drug Administration said the approval on Wednesday was...
Read More
FILE - In this Monday, Aug. 28, 2017, file photo, Rhonda Worthington talks on her cellphone with a 911 dispatcher as she gets out of her car after her vehicle become stalled in rising floodwaters from Harvey in Houston. Cellphone networks are largely functional in the Texas and Louisiana regions hit by Harvey, as cellphone companies brought in supplemental equipment and backup power and turned to drones to diagnose problems. (AP Photo/LM Otero, File)
August 31, 2017 - 4:48 am
NEW YORK (AP) — Roads, refineries and other infrastructure have taken a beating in the Texas and Louisiana regions hit by Harvey — but cellphone networks so far remain largely functional. One reason: Big carriers brought in supplemental equipment and backup power and turned to drones to diagnose...
Read More
FILE - In this Monday, Aug. 28, 2017, file photo, Rhonda Worthington talks on her cellphone with a 911 dispatcher as she gets out of her car after her vehicle become stalled in rising floodwaters from Harvey in Houston. Cellphone networks are largely functional in the Texas and Louisiana regions hit by Harvey, as cellphone companies brought in supplemental equipment and backup power and turned to drones to diagnose problems. (AP Photo/LM Otero, File)
August 31, 2017 - 4:48 am
NEW YORK (AP) — Roads, refineries and other infrastructure have taken a beating in the Texas and Louisiana regions hit by Harvey — but cellphone networks so far remain largely functional. One reason: Big carriers brought in supplemental equipment and backup power and turned to drones to diagnose...
Read More
In this July 9, 2015, photo, provided by Novartis Pharmaceuticals Corp., human T cells belonging to cancer patients arrive at Novartis Pharmaceuticals Corp.'s Morris Plains, N.J., facility. The Food and Drug Administration (FDA) approved the first treatment that genetically engineers patients’ own blood cells into an army of leukemia-fighting assassins. Manufacturer Novartis will create those turbocharged cells in this facility and ship them back to hospitals to infuse into patients. (Brent Stirton/Novartis Pharmaceuticals Corp. via AP)
August 30, 2017 - 5:26 pm
WASHINGTON (AP) — Opening a new era in cancer care, U.S. health officials on Wednesday approved a breakthrough treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia. The Food and Drug Administration called the approval...
Read More
In this July 9, 2015, photo, provided by Novartis Pharmaceuticals Corp., human T cells belonging to cancer patients arrive at Novartis Pharmaceuticals Corp.'s Morris Plains, N.J., facility. The Food and Drug Administration (FDA) approved the first treatment that genetically engineers patients’ own blood cells into an army of leukemia-fighting assassins. Manufacturer Novartis will create those turbocharged cells in this facility and ship them back to hospitals to infuse into patients. (Brent Stirton/Novartis Pharmaceuticals Corp. via AP)
August 30, 2017 - 5:26 pm
WASHINGTON (AP) — Opening a new era in cancer care, U.S. health officials on Wednesday approved a breakthrough treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia. The Food and Drug Administration called the approval...
Read More
FILE - In this Aug. 10, 2017 file photo, Defense Secretary Jim Mattis speaks in Mountain View, Calif. Mattis said Wednesday, Aug. 30, 2017, the U.S. remains focused on diplomacy as well as military readiness. Amid the heightened tensions on the divided Korean Peninsula, the U.S. and South Korea have been conducting annual military drills. (AP Photo/Jeff Chiu, File)
August 30, 2017 - 12:49 pm
WASHINGTON (AP) — President Donald Trump said Wednesday that "talking is not the answer" to North Korea, after it upped the stakes in its standoff with Washington by calling for more weapons launches in the Pacific. Trump's morning tweet followed a highly provocative North Korean missile test...
Read More

Pages